Eager for a Lifetime of Passive Income? These 5 Stocks Deserve Long-Term Investment Now
In the world of dividend investing, consistency is key. For those seeking passive income with potential for decades of growth, several healthcare companies stand out as top picks, boasting long streaks of annual dividend increases and strong market positions. These Dividend Kings and Aristocrats, known for their financial stability and shareholder value focus, have proven track records of dividend growth.
Becton Dickinson (BDX), AbbVie (ABBV), and Abbott Laboratories (ABT) are three such companies that shine in the healthcare sector.
Becton Dickinson (BDX), a medical devices manufacturer, has an impressive 53-year streak of dividend increases. With a vast product portfolio and strong cash flow, the company is well-positioned to continue supporting dividend growth [1][2].
AbbVie (ABBV), another Dividend King, also boasts a 53-year streak (including years from Abbott before the spinoff). The company's focus on pharmaceuticals, particularly immunology and oncology drugs, ensures strong, high-yield payouts [1][2].
Abbott Laboratories (ABT), with a 52-year dividend growth streak, is a diversified healthcare company that offers medical devices, diagnostics, and nutrition products. The company's dividend is very safe, with a steady yield [2].
Other notable mentions include Johnson & Johnson (JNJ), another Dividend King with a streak of 62 consecutive annual dividend increases, and PepsiCo, a non-healthcare company with a 53-year dividend growth streak that provides context for the dividend-focused discussion [1][2].
Johnson & Johnson (JNJ) is a leading developer of pharmaceuticals, medical devices, and products, with a payout ratio of 49% of 2025 earnings estimates. The company is growing earnings at a mid-single-digit percentage pace annually [1].
Abbott Laboratories (ABT), after spinning off its pharmaceutical business, now focuses on medical devices for cardiovascular and diabetes patients, diagnostics, and consumer nutrition products. Analysts project 10% annualized earnings growth over the next three to five years for Abbott Laboratories [1].
In conclusion, for passive income with decades of dividend growth in healthcare, Becton Dickinson, AbbVie, and Abbott Laboratories are the top picks. They combine long dividend increase streaks (over 50 years), strong market positions, and stable cash flows that support ongoing dividend raises [1][2]. These companies offer investors the potential for consistent returns and a focus on shareholder value, making them attractive options for long-term dividend growth portfolios.
[1] Yahoo Finance, accessed on 2023-03-10. [2] The Motley Fool, accessed on 2023-03-10.
- Investing in companies like Becton Dickinson, AbbVie, and Abbott Laboratories, with their strong roots in science and health-and-wellness, could potentially provide investors with passive income for several decades, given their consistent track records of financial stability, shareholder value focus, and dividend growth.
- As these healthcare giants, such as Becton Dickinson, AbbVie, and Abbott Laboratories, continue to innovate and expand in their respective fields, they offer an opportunity for individuals interested in investing to benefit from both their stable dividends and the potential for long-term gains in the rapidly growing health-and-wellness and finance sectors.
